Literature DB >> 23962784

Myosin light chain kinase inhibitor attenuates atherosclerosis and permeability via reduced endothelial tight junction in rabbits.

Hua-Qing Zhu1, Xiao-Bian Wang, Jian-Xiong Han, Ze-Ping Hu, Yi Wang, Qing Zhou, Shu-Yu Gui, Yuan Wang.   

Abstract

Entities:  

Keywords:  Atherosclerosis; ML7; Myosin light chain kinase; Permeability; Tight junction

Mesh：

Substances：

Year:  2013        PMID： 23962784     DOI： 10.1016/j.ijcard.2013.07.219

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  5 in total

Review 1.  Regulation of pulmonary endothelial barrier function by kinases.

Authors:  Nektarios Barabutis; Alexander Verin; John D Catravas
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-09-23       Impact factor: 5.464

2.  Myosin light chain kinase inhibitor ML7 improves vascular endothelial dysfunction via tight junction regulation in a rabbit model of atherosclerosis.

Authors:  Xiaowen Cheng; Xiaobian Wang; Yufeng Wan; Qing Zhou; Huaqing Zhu; Yuan Wang
Journal:  Mol Med Rep       Date:  2015-06-22       Impact factor: 2.952

Review 3.  Myosin Light Chain Kinase: A Potential Target for Treatment of Inflammatory Diseases.

Authors:  Yongjian Xiong; Chenou Wang; Liqiang Shi; Liang Wang; Zijuan Zhou; Dapeng Chen; Jingyu Wang; Huishu Guo
Journal:  Front Pharmacol       Date:  2017-05-23       Impact factor: 5.810

4.  DT-13 Ameliorates TNF-α-Induced Vascular Endothelial Hyperpermeability via Non-Muscle Myosin IIA and the Src/PI3K/Akt Signaling Pathway.

Authors:  Yuanyuan Zhang; Yuwei Han; Yazheng Zhao; Yanni Lv; Yang Hu; Yisha Tan; Xueyuan Bi; Boyang Yu; Junping Kou
Journal:  Front Immunol       Date:  2017-08-14       Impact factor: 7.561

5.  Monocytic cell junction proteins serve important roles in atherosclerosis via the endoglin pathway.

Authors:  Lina Chen; Zhongliang Chen; Menghua Ge; Oushan Tang; Yinhong Cheng; Haoliang Zhou; Yu Shen; Fengming Qin
Journal:  Mol Med Rep       Date:  2017-09-08       Impact factor: 2.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.